Skip to main content
. 2020 Aug 25;21(17):6115. doi: 10.3390/ijms21176115

Table 1.

Summary of the potencies (EC50) (in nM) and efficacies (Emax)* of synthetic cannabinoids (GCs) determined using cell assays.

Synthetic Cannabinoids GTP Binding cAMP β-arrestin2 GIRK Channel Cells Assay Ref.
Aminoalkylindoles
Cyclohexylphenols
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
WIN 55,212-2 100 217 HEK293 [35S]GTPγS [46]
32 65 ± 5a HEK293 GloSensor [47]
13 70 ± 4b HEK293 BRET [48]
5 64 ± 6a HEK293 GloSensor [49]
46 114 ± 5c HEK293 BRET [50]
47 113c HEK293 HitHunter [51]
7.6 92 ± 3c 1288 HEK293 BRET [52]
14 107 ± 1c 182 89 ± 2c CHO Pathfinder [53]
570 59 ± 13 Neuronsd BRET [54]
27 100e AtT20 MPSD [55]
282 100e AtT20 MPSD [28]
309 100e AtT20 MPSD [56]
CP-55,940 17 163 HEK293 [35S]GTPγS [57]
8 199b 320 47 ± 8a HEK293 GloSensor [47]
0.4 95 ± 3 HEK293 [35S]GTPγS [46]
0.3 100 CHO HTRF [58]
8 58 ± 3b HEK293 BRET [48]
0.6 100 178 57 ± 3c HEK293 BRET [52]
0.2 100 ± 3c 11 95 ± 2c CHO Pathfinder [53]
138 49 ± 2c HEK293 BRET [50]
350 86 ± 4 Neuronsd BRET [54]
23 100c AtT20 MPSD [59]
17 100c AtT20 MPSD [60]
Naphtholylindoles EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
AM-1221 17 163c HEK293 [35S]GTPγS [57]
AM-2201 24 99f HEK293 NanoBiT [61]
37 111 ± 6e AtT20 MPSD [28]
JWH-018 0.7 102 ± 10 1.7 90 ± 78 116 ± 16 CHO 3H-cAMP [62]
41 99f HEK293 NanoBiT [61]
16 64 ± 3 HEK293 BRET [48]
37 102f HEK293 NanoBiT [63]
18 116b AtT20 MPSD [28]
JWH-122 3 102c CHO HTRF [58]
72 HEK293 NanoLuc [64]
N-(5-chloropentyl) 74 289c HEK293 NanoBiT [61]
N-(5-bromopentyl) 284 261c HEK293 NanoBiT [61]
N-(5-I=iodopentyl) 215 152c HEK293 NanoBiT [61]
JWH-210 116 287 HEK293 [35S]GTPγS [57]
25 HEK293 NanoLuc [64]
111 98c CHO HTRF [58]
Tetramethylcyclo-propyls EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
UR-144 426 HEK293 NanoLuc [65]
Synthetic Cannabinoids GTP Binding cAMP β-arrestin2 GIRK Channel Cells Assay Ref.
Tetramethylcyclo-propyls cont. EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
UR-144 421 94 ± 4e AtT20 MPSD [28]
XLR-11 98 110e AtT20 MPSD [28]
3981 65 ± 5a HEK293 GloSensor [47]
25 107 ± 2c 389 88 ± 2c HEK293 BRET [50]
63 63 ± 2 HEK293 BRET [48]
Indole & Indozole
Carboxamides
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax EC50 Emax
(%)
AB-CHMINACA 7.4 205 HEK293 [35S]GTPγS [66]
0.28 CHO HitHunter [67]
0.95 100 ± 4c 30.9 110 ± 4 HEK293 BRET [50]
251 51 ± 2b HEK293 GloSensor [47]
3.45 390.5f HEK293 NanoBiT [63]
7.8 142c AtT20 MPSD [60]
ADB-CHMINACA
(MAB-CHMINACA)
.34 262.6f HEK293 NanoBiT [63]
AB-PINACA 71 192 HEK293 [35S]GTPγS [66]
79.4 69 ± 3b HEK293 GloSensor [47]
19 288e HEK293 NanoBit [61]
1.2 103 ± 4e AtT20 MPSD [59]
6.5 142 ± 15c AtT20 MPSD [60]
5F-AB-PINACA 2.45 102 ± 7 HEK293 [35S]GTPγS [46]
66 267f HEK293 NanoBiT [61]
0.48 94 ± 6c AtT20 MPSD [59]
2.8 132 ± 9c AtT20 MPSD [60]
5F-ADB-PINACA 0.24 91 ± 7c AtT20 MPSD [59]
2.8 308f HEK293 NanoBiT [63]
ADB-FUBICA 2.6 113 ± 8c AtT20 MPSD [59]
12.3 314f HEK293 NanoBiT [61]
5F-CUMYL-PINACA 0.5 107 ± 6c 16.9 97 ± 7 HEK293 BRET [50]
AB-FUBINACA 0.79 116 ± 4c 33 107 ± 4c HEK293 BRET [50]
1.36 CHO 3H-cAMP [68]
16 324f HEK293 NanoBiT [61]
1.8 108 ± 7c AtT20 MPSD [59]
2.1 151 ± 14c AtT20 MPSD [60]
ABD-FUBINACA 0.69 339f HEK293 NanoBiT [61]
1.20 152 ± 11c AtT20 MPSD [59]
5F-AMB-PINACA 1.3 96 ± 8c HEK293 [35S]GTPγS [46]
0.6 98 ± 1c 30 100 ± 2 HEK293 BRET [50]
15 259f HEK293 NanoBiT [63]
1.9 109 ± 3c AtT20 MPSD [59]
5F-MDMB-PINACA 0.29 111 ± 9c HEK293 [35S]GTPγS [46]
0.84 319f HEK293 NanoBiT [63]
1.78 331f HEK293 NanoBiT [26]
MDMB-CHMICA 0.14 CHO HitHunter [67]
0.7 117 ± 4c 32 108 ± 1 HEK293 BRET [50]
1.77 285f HEK293 NanoBiT [63]
AMB-CHMINACA 3.91 360f HEK293 NanoBiT [63]
Synthetic Cannabinoids GTP Binding cAMP β-arrestin2 GIRK Channel Cells Assay Ref.
Indole & Indozole
Carboxamides cont.
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
EC50 Emax
(%)
MDMB-CHMINACA 0.78 227f HEK293 NanoBiT [63]
MDMB-FUBICA 1.0 108 ± 5c 43 104 ± 2 HEK293 BRET [50]
MDMB-FUBINACA 0.27 75 HEK293 [35S]GTPγS [46]
0.65 216 CHO LanceUltra [69]
0.36 241f HEK293 NanoBit [63]
5F-MDMB-PICA 0.17 109 ± 7 20 111 ± 4 HEK293 BRET [50]
0.63 60 ± 4b HEK293 BRET [48]

* - EC50s were normalized as indicated by a-f (below); a – compared to 65% inhibition with WIN 55,212-2; b – percent of control measurements; c – maximal effect compared to CP55,940 (100%); d – striatal medium spiny projection neurons; e – maximal effect compared to WIN 55,212-2 (100%); f – maximal effect compared to JWH-018 (100%); BRET = bioluminescence resonance energy transfer; MPSD = membrane potential-sensitive dye; HTRF = homogeneous time-resolved fluorescence; NanoBiT = nanobinary technology assay; NanoLuc = nanoluciferase reporter assay.